p.75 抽出テキスト

9. Sanaiha Y, Lyons R, Benharash P. Infective endocarditis in intravenous drug users. Trends Cardiovasc Med 2020;30:491–497. https://doi.org/10.1016/j.tcm.2019.11.007 10. Pericas JM, Llopis J, Athan E, Hernandez-Meneses M, Hannan MM, Murdoch DR, et al. Prospective cohort study of infective endocarditis in people who inject drugs. J Am Coll Cardiol 2021;77:544–555. https://doi.org/10.1016/j.jacc.2020.11.062 11. Thornhill MH, Crum A, Campbell R, Stone T, Lee EC, Bradburn M, et al. Temporal association between invasive procedures and infective endocarditis. Heart 2023;109: 223–231. https://doi.org/10.1136/heartjnl-2022-321519 12. Maeda K, Hirai Y, Nashi M, Yamamoto S, Taniike N, Takenobu T. Clinical features and antimicrobial susceptibility of oral bacteria isolated from the blood cultures of patients with infective endocarditis. J Dent Sci 2022;17:870–875. https://doi.org/10.1016/j.jds. 2021.09.023 13. Thornhill MH, Gibson TB, Cutler E, Dayer MJ, Chu VH, Lockhart PB, et al. Antibiotic prophylaxis and incidence of endocarditis before and after the 2007 AHA recommendations. J Am Coll Cardiol 2018;72:2443–2454. https://doi.org/10.1016/j.jacc.2018.08. 2178 14. Thornhill MH, Dayer MJ, Nicholl J, Prendergast BD, Lockhart PB, Baddour LM. An alarming rise in incidence of infective endocarditis in England since 2009: why? Lancet 2020;395:1325–1327. https://doi.org/10.1016/S0140-6736(20)30530-4 15. Dayer MJ, Prendergast BD, Thornhill MH, Baddour LM. Why are we seeing an increasing incidence of infective endocarditis in the UK? Br J Hosp Med (Lond) 2020;81:1–4. https://doi.org/10.12968/hmed.2020.0263 16. Quan TP, Muller-Pebody B, Fawcett N, Young BC, Minaji M, Sandoe J, et al. Investigation of the impact of the NICE guidelines regarding antibiotic prophylaxis during invasive dental procedures on the incidence of infective endocarditis in England: an electronic health records study. BMC Med 2020;18:84. https://doi.org/10.1186/ s12916-020-01531-y 17. Vahasarja N, Lund B, Ternhag A, Gotrick B, Olaison L, Hultin M, et al. Incidence of infective endocarditis caused by viridans group streptococci in Sweden – effect of cessation of antibiotic prophylaxis in dentistry for risk individuals. J Oral Microbiol 2020;12: 1768342. https://doi.org/10.1080/20002297.2020.1768342 18. Williams ML, Doyle MP, McNamara N, Tardo D, Mathew M, Robinson B. Epidemiology of infective endocarditis before versus after change of international guidelines: a systematic review. Ther Adv Cardiovasc Dis 2021;15: 17539447211002687. https://doi.org/10.1177/17539447211002687 19. Ostergaard L, Bruun NE, Voldstedlund M, Arpi M, Andersen CO, Schonheyder HC, et al. Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study. Eur Heart J 2019;40:3237–3244. https://doi.org/10.1093/ eurheartj/ehz327 20. Kim I-C, Chang S, Hong G-R, Lee SH, Lee S, Ha J-W, et al. Comparison of cardiac computed tomography with transesophageal echocardiography for identifying vegetation and intracardiac complications in patients with infective endocarditis in the era of 3-dimensional images. Circ Cardiovasc Imaging 2018;11:e006986. https://doi.org/10.1161/ CIRCIMAGING.117.006986 21. Salaun E, Habib G. Beyond standard echocardiography in infective endocarditis: computed tomography, 3-dimensional imaging, and multi-imaging. Circ Cardiovasc Imaging 2018;11:e007626. https://doi.org/10.1161/CIRCIMAGING.118.007626 22. Pizzi MN, Roque A, Fernandez-Hidalgo N, Cuellar-Calabria H, Ferreira-Gonzalez I, Gonzalez-Alujas MT, et al. Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation 2015;132:1113–1126. https://doi.org/10.1161/ CIRCULATIONAHA.115.015316 23. DeSimone DC, Lahr BD, Anavekar NS, Sohail MR, Tleyjeh IM, Wilson WR, et al. Temporal trends of infective endocarditis in Olmsted County, Minnesota, between 1970 and 2018: a population-based analysis. Open Forum Infect Dis 2021;8:ofab038. https://doi.org/10.1093/ofid/ofab038 24. Giannitsioti E, Pefanis A, Gogos C, Lekkou A, Dalekos GN, Gatselis N, et al. Evolution of epidemiological characteristics of infective endocarditis in Greece. Int J Infect Dis 2021;106:213–220. https://doi.org/10.1016/j.ijid.2021.03.009 25. Jensen AD, Bundgaard H, Butt JH, Bruun NE, Voldstedlund M, Torp-Pedersen C, et al. Temporal changes in the incidence of infective endocarditis in Denmark 1997–2017: a nationwide study. Int J Cardiol 2021;326:145–152. https://doi.org/10.1016/j.ijcard.2020. 10.029 26. Keller K, von Bardeleben RS, Ostad MA, Hobohm L, Munzel T, Konstantinides S, et al. Temporal trends in the prevalence of infective endocarditis in Germany between 2005 and 2014. Am J Cardiol 2017;119:317–322. https://doi.org/10.1016/j.amjcard.2016.09. 035 27. Shah ASV, McAllister DA, Gallacher P, Astengo F, Rodriguez Perez JA, Hall J, et al. Incidence, microbiology, and outcomes in patients hospitalized with infective endocarditis. Circulation 2020;141:2067–2077. https://doi.org/10.1161/CIRCULATIONAHA. 119.044913 28. Ortega-Loubon C, Munoz-Moreno MF, Andres-Garcia I, Alvarez FJ, Gomez-Sanchez E, Bustamante-Munguira J, et al. Nosocomial vs. community-acquired infective endocarditis in Spain: location, trends, clinical presentation, etiology, and survival in the 21st century. J Clin Med 2019;8:1755. https://doi.org/10.3390/jcm8101755 29. Olmos C, Vilacosta I, Fernandez-Perez C, Bernal JL, Ferrera C, Garcia-Arribas D, et al. The evolving nature of infective endocarditis in Spain: a population-based study (2003 to 2014). J Am Coll Cardiol 2017;70:2795–2804. https://doi.org/10.1016/j.jacc.2017.10. 005 30. Altini C, Lavelli V, Niccoli-Asabella A, Sardaro A, Branca A, Santo G, et al. Comparison of the diagnostic value of MRI and whole body (18)F-FDG PET/CT in diagnosis of spondylodiscitis. J Clin Med 2020;9:1581. https://doi.org/10.3390/jcm9051581 31. Holle SLK, Andersen MH, Klein CF, Bruun NE, Tonder N, Haarmark C, et al. Clinical usefulness of FDG-PET/CT for identification of abnormal extra-cardiac foci in patients with infective endocarditis. Int J Cardiovasc Imaging 2020;36:939–946. https://doi.org/ 10.1007/s10554-020-01787-8 32. Kim S-J, Pak K, Kim K, Lee JS. Comparing the diagnostic accuracies of F-18 fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spondylodiscitis: a meta-analysis. Spine (Phila Pa 1976) 2019;44: E414–E422. https://doi.org/10.1097/BRS.0000000000002861 33. Sifaoui I, Oliver L, Tacher V, Fiore A, Lepeule R, Moussafeur A, et al. Diagnostic performance of transesophageal echocardiography and cardiac computed tomography in infective endocarditis. J Am Soc Echocardiogr 2020;33:1442–1453. https://doi.org/10. 1016/j.echo.2020.07.017 34. Venet M, Jalal Z, Ly R, Malekzadeh-Milani S, Hascoet S, Fournier E, et al. Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography computed tomography in prosthetic pulmonary valve infective endocarditis. JACC Cardiovasc Imaging 2022;15:299–308. https://doi.org/10.1016/j.jcmg.2021.07.015 35. Wang TKM, Bin Saeedan M, Chan N, Obuchowski NA, Shrestha N, Xu B, et al. Complementary diagnostic and prognostic contributions of cardiac computed tomography for infective endocarditis surgery. Circ Cardiovasc Imaging 2020;13:e011126. https://doi.org/10.1161/CIRCIMAGING.120.011126 36. Camou F, Dijos M, Barandon L, Cornolle C, Greib C, Laine M, et al. Management of infective endocarditis and multidisciplinary approach. Med Mal Infect 2019;49:17–22. https://doi.org/10.1016/j.medmal.2018.06.007 37. El-Dalati S, Cronin D, Riddell JT, Shea M, Weinberg RL, Washer L, et al. The clinical impact of implementation of a multidisciplinary endocarditis team. Ann Thorac Surg 2022;113:118–124. https://doi.org/10.1016/j.athoracsur.2021.02.027 38. Elad B, Perl L, Hamdan A, Yahav D, Atamna A, Shaked H, et al. The clinical value of the endocarditis team: insights from before and after guidelines implementation strategy. Infection 2022; 50:57–64. https://doi.org/10.1007/s15010-021-01636-3 39. Gibbons EF, Huang G, Aldea G, Koomalsingh K, Klein JW, Dhanireddy S, et al. A multidisciplinary pathway for the diagnosis and treatment of infectious endocarditis. Crit Pathw Cardiol 2020;19:187–194. https://doi.org/10.1097/HPC.0000000000000224 40. Kaura A, Byrne J, Fife A, Deshpande R, Baghai M, Gunning M, et al. Inception of the ‘endocarditis team’ is associated with improved survival in patients with infective endocarditis who are managed medically: findings from a before-and-after study. Open Heart 2017;4:e000699. https://doi.org/10.1136/openhrt-2017-000699 41. Ruch Y, Mazzucotelli JP, Lefebvre F, Martin A, Lefebvre N, Douiri N, et al. Impact of setting up an “endocarditis team” on the management of infective endocarditis. Open Forum Infect Dis 2019;6:ofz308. https://doi.org/10.1093/ofid/ofz308 42. European Committee on Antimicrobial Susceptibility Testing. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 12.0, 2022. http://www.eucast.org. 43. Iversen K, Ihlemann N, Gill SU, Madsen T, Elming H, Jensen KT, et al. Partial oral versus intravenous antibiotic treatment of endocarditis. N Engl J Med 2019;380:415–424. https://doi.org/10.1056/NEJMoa1808312 44. Wildenthal JA, Atkinson A, Lewis S, Sayood S, Nolan NS, Cabrera NL, et al. Outcomes of partial oral antibiotic treatment for complicated Staphylococcus aureus bacteremia in people who inject drugs. Clin Infect Dis 2022;76:487–496. https://doi.org/10.1093/cid/ ciac714 45. Pericas JM, Llopis J, Munoz P, Gonzalez-Ramallo V, Garcia-Leoni ME, de Alarcon A, et al. Outpatient parenteral antibiotic treatment vs hospitalization for infective endocarditis: validation of the OPAT-games criteria. Open Forum Infect Dis 2022;9:ofac442. https://doi.org/10.1093/ofid/ofac442 46. Fernandez-Galilea A, Estella A, Garcia-Garmendia JL, Loza A, Palacios-Garcia I, Sierra-Camerino R, et al. Clindamycin but not intravenous immunoglobulins reduces mortality in a retrospective cohort of critically ill patients with bacteremic group A streptococcal infections. Rev Esp Quimioter 2022;35:475–481. https://doi.org/10. 37201/req/030.2022 47. Thornhill MH, Jones S, Prendergast B, Baddour LM, Chambers JB, Lockhart PB, et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. Eur Heart J 2018;39:586–595. https://doi.org/10.1093/eurheartj/ehx655 48. Duval X, Millot S, Chirouze C, Selton-Suty C, Moby V, Tattevin P, et al. Oral streptococcal endocarditis, oral hygiene habits, and recent dental procedures: a case-control study. Clin Infect Dis 2017;64:1678–1685. https://doi.org/10.1093/cid/cix237 49. Lockhart PB, Brennan MT, Thornhill M, Michalowicz BS, Noll J, Bahrani-Mougeot FK, et al. Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia. J Am Dent Assoc 2009;140:1238–1244. https://doi.org/10.14219/jada.archive.2009.0046 Downloaded from academic.oup.com/eurheartj/article/44/39/3948/7243107 by guest on 07 October 2026